zoeti spun lead global manufactur medic vaccin
livestock revenu companion anim revenu
stellar perform attribut much stock out-performance
manag execut oper perform coupl signific
growth ztss dermatolog portfolio apoquel cytopoint well
simparica anim health industri face certain headwind
livestock market soft dairy/cattl market african swine fever think
companion anim sale continu deliv outsiz growth forese
futur given recent move stock think there grow confid
simparica trio approv time launch ahead next year flea
tick season maintain buy rate rais price target
pole posit tripl combo year holi grail
companion anim market oral tripl combo flea tick
heartworm tablet boehringer-ingelheim merial tripl nexgard
spectra europ approv
case heartworm resist mississippi delta region
lead us believ issu around effect
macrocycl lacton best known commerci ivermectin activ
ingredi heartgard hand zoetiss heartworm prevent
proheart differ activ ingredi moxidectin base
studi weve read think simparica trio could combin sarolan
activ ingredi simparica moxidectin/imidacloprid doxycyclin
regardless manag seem confid fda approv ahead
next year flea tick season suspect approv could ahead
vmx januari western vet februari
market educ veterinari commun
livestock headwind persist anim health industri continu face
livestock headwind primarili challeng dairi market
impact african swine fever outsid cattl market
 remain healthi although placement may given
histor delay plant higher corn price like pressur feeder cattl
cattl like stay pastur longer given favor condit
meat altern like impact livestock busi
question lot attent altern meat market
due success ipo beyond meat bynd/not cover
believ anim protein market affect altern meat clearli
demand anim protein remain solid especi intern
market forese chang anytim soon long-term
think growth continu fuel emerg market like china
part asia well latin america grow middl class gain
wealth addit think cost meat altern especi lab
develop meat far expens see broader adopt global
introduc estim rais price target although
near all-tim high think stock continu perform well
next month driven good companion anim product sale
rais price target base new estim
